|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Operating activities | |||||
| Net income | |||||
| Add (deduct) non-cash items: | |||||
| (Gain) loss on investments | |||||
| Stock-based compensation | |||||
| Depreciation of property and equipment | |||||
| Deferred income tax expense | |||||
| Current income tax expense | |||||
| Other items | |||||
| Shares received on recognition of a previously unrecorded contingent asset | |||||
| Income taxes paid | |||||
| Changes in: | |||||
| Fees receivable | |||||
| Other assets | |||||
| Accounts payable, accrued liabilities and compensation payable | |||||
| Cash provided by (used in) operating activities | |||||
| Investing activities | |||||
| Purchase of investments | |||||
| Sale of investments | |||||
| Purchase of property and equipment | |||||
| Proceeds received on exit of non-core businesses | |||||
| Management contract consideration | |||||
| Cash provided by (used in) investing activities | |||||
| Financing activities | |||||
| Acquisition of common shares for equity incentive plan | |||||
| Acquisition of common shares under normal course issuer bid | |||||
| Cash received on exercise of stock options | |||||
| Repayment of lease liabilities | |||||
| Contributions from non-controlling interest | |||||
| Net advances (repayments) from loan facility | |||||
| Advances from loan facility | |||||
| Repayments of loan facility | |||||
| Dividends paid | |||||
| Cash provided by (used in) financing activities | |||||
| Effect of foreign exchange on cash balances | |||||
| Net increase (decrease) in cash and cash equivalents during the year | |||||
| Cash and cash equivalents, beginning of the year | |||||
| Cash and cash equivalents, end of the year | |||||
| Cash and cash equivalents: | |||||
| Cash | |||||
| Short-term deposits |
Loading...
